观点葛兰素史克

China is making an example of GlaxoSmithKline

Eighteen months into China’s anti-corruption campaign, officials are still being removed from positions of power every day – and corporations and business people are increasingly caught up in the investigations, too.

GlaxoSmithKline was caught in the middle of this campaign a year ago, with evidence emerging that the UK drugmaker’s managers bribed doctors and officials with large sums of money. The scandal is among the most high-profile corporate corruption stories in China, with television stations repeatedly broadcasting the lurid details. With the company’s confirmation last month that executives had been emailed a secretly filmed sex video of Mark Reilly, then the company’s China head, the scandal made headlines worldwide.

Executives are asking why GSK, of all the multinationals operating in China, has been picked on – and what the case means for their own businesses in the country.

您已阅读19%(897字),剩余81%(3865字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×